Study guide

Secondary hypertension and arterial disease

AMC CAT MCQ Examination AMC Part 1

Track your progress as you read

Finished sections get a check mark.

1 Acute Coronary Syndromes & ECG Localization

ACS recognition and ECG localisation Reperfusion and infarction complications

2 Heart Failure, Cardiogenic Shock & Cardiac Arrhythmias

Heart failure assessment and treatment Arrhythmias and conduction emergencies

3 Systemic Hypertension & Peripheral Vascular Disease

Blood pressure and cardiovascular risk Secondary hypertension and arterial disease

4 Valvular Heart Disease, Infective Endocarditis & Pericarditis

Aortic and mitral valve disease Endocarditis and pericardial emergencies

5 Asthma & COPD Acute Flares and Maintenance

Asthma and COPD diagnosis and maintenance Acute asthma and COPD exacerbations

6 Pneumonia, pleural disease and respiratory failure

Pneumonia and infected pleural collections Pulmonary embolism, effusions and pneumothorax Respiratory failure, ARDS and sepsis

7 GI bleeding, bowel inflammation and malabsorption

GI bleeding assessment and resuscitation Varices, ulcers, reflux and lower GI bleeding IBD patterns and severe colitis assessment IBD treatment, coeliac disease and IBS

8 Chronic Liver Disease, Cirrhosis Complications & Acute Hepatitis

Cirrhosis diagnosis and prognosis Decompensation, viral hepatitis and surveillance

9 Diabetes, thyroid and adrenal disease

Diabetes diagnosis and ongoing care DKA, HHS and complication monitoring Thyroid disease assessment Thyroid emergencies and adrenal disease

10 Acute Kidney Injury, Chronic Kidney Disease & Fluid/Electrolyte Emergencies

AKI and chronic kidney disease Potassium and sodium emergencies

11 Anaemias, Inflammatory Arthropathies & Geriatric Comprehensive Assessment

Anaemia, bruising and blood disorders Arthritis, autoimmune disease and geriatric care

12 Evaluation of the Acute Abdomen, Peritonitis & Appendicitis

Abdominal pain, peritonitis and resuscitation Appendicitis diagnosis and treatment Perforation and mesenteric ischaemia

13 Small and Large Bowel Obstruction & Colorectal Surgical Pathology

Small bowel obstruction Colonic obstruction, volvulus and cancer recognition Colorectal care, diverticulitis and anorectal symptoms

14 Gallbladder Disease, Biliary Tract Infections & Acute Pancreatitis

Gallstones and biliary obstruction Cholangitis and pancreatitis diagnosis Pancreatitis severity and treatment

15 Advanced Trauma Life Support, Primary Survey & Life-Threatening Thoracic Injuries

Trauma primary survey and adjuncts Chest trauma and immediate threats

16 Traumatic Brain Injury, Intracranial Haemorrhage & Spinal Cord Clearance

Head injury, imaging and haemorrhage Herniation and spinal cord injury

17 Major Fractures, Joint Dislocations & Acute Compartment Syndrome

Fracture assessment and open injuries Compartment syndrome, dislocations and pelvic injury

18 Thermal Burns, Haemorrhagic Shock Resuscitation & Surgical Wound Care

Burn assessment and fluid resuscitation Bleeding shock, wound care and tetanus

19 Aortic Aneurysms & Acute Arterial Limb Ischaemia

Aneurysm recognition and planned care Ruptured aneurysm and acute limb ischaemia

20 Urological Emergencies, Testicular Torsion & Haematuria Investigation

Retention, stones and obstructed infection Scrotal pain and haematuria

21 Preoperative Risk Stratification & Postoperative Surgical Complications

Preoperative assessment and medicines Postoperative complications and prevention

22 Early Pregnancy Bleeding, Ectopic Pregnancy & Antenatal Screening

Miscarriage and ectopic pregnancy Antenatal screening and early-pregnancy comparisons

23 Hypertensive Disorders of Pregnancy & Medical Complications in Pregnancy

Pregnancy hypertension and preeclampsia Eclampsia, HELLP and antepartum bleeding

24 Intrapartum Monitoring, Postpartum Haemorrhage & Obstetric Emergencies

Labour physiology and CTG assessment CTG response and postpartum haemorrhage Obstetric emergencies and preterm birth

25 Abnormal Uterine Bleeding, Pelvic Pain & Endometriosis

Abnormal bleeding and structural causes Endometrial sampling and endometriosis PCOS diagnosis and long-term care

26 Contraception, Emergency Contraception & Pregnancy Termination

Contraceptive choice and missed pills Emergency contraception and abortion

27 Australian Cervical Screening Program & Gynaecological Malignancies

Cervical screening and cervical cancer Endometrial and ovarian cancer

28 Neonatal Resuscitation, Congenital Conditions & Neonatal Jaundice

Newborn resuscitation, Apgar and cyanosis Neonatal jaundice assessment Jaundice treatment and congenital screening

29 Developmental Milestones, Growth Charts & Failure to Thrive

Developmental milestones Regression, autism and support Faltering growth and developmental comparisons

30 The Limping Child, Septic Arthritis vs Transient Synovitis & Paediatric Hip Conditions

Limp assessment and septic-joint risk Joint-infection management and Perthes disease SUFE and paediatric hip comparisons

31 Croup, Bronchiolitis, Paediatric Asthma & Anaphylaxis

Croup Bronchiolitis Paediatric asthma Paediatric anaphylaxis

32 Evaluation of the Febrile Child, Sepsis & Meningococcal Disease

Febrile neonates and young infants Meningococcal disease and paediatric sepsis Bacterial meningitis and CSF interpretation Kawasaki disease and follow-up

33 Paediatric Surgical Abdomen, Dehydration & Child Protection / Non-Accidental Injury

Pyloric stenosis Intussusception and dehydration Child protection and injury assessment

34 The Mental State Examination & Suicide Risk Stratification

Mental state examination and psychotic symptoms Suicide formulation and mental health law

35 Major Depressive Disorder, Bipolar Affective Disorder & Mood Stabilisers

Depression assessment and treatment Serotonin toxicity and bipolar presentations Mood stabilisers and ECT

36 Generalised Anxiety, Panic Disorder, PTSD & Obsessive-Compulsive Disorder

Anxiety, panic and agoraphobia OCD and trauma-related disorders

37 Schizophrenia, Acute Psychosis & Antipsychotic Management

Psychosis assessment and antipsychotics Clozapine and severe adverse effects

38 Substance Use Disorders & Acute Withdrawal Syndromes

Substance disorders and alcohol withdrawal Wernicke disease, opioids and stimulants

39 Delirium vs Dementia, Perinatal Mood Disorders & Paediatric Psychiatry

Delirium and dementia assessment Cognitive behaviour, perinatal and childhood psychiatry

40 Medicare, PBS, AHPRA & Good Medical Practice Framework

Australian health services and Medicare PBS access and professional registration Professional boundaries and notifications

41 Informed Consent (Rogers v Whitaker), Mental Capacity & Involuntary Treatment

Consent, material risks and young people Capacity, refusal and substitute decisions

42 Patient Privacy, Confidentiality Exceptions & Mandatory Notifications

Privacy, disclosure and child reporting Driving fitness and threat disclosure

43 First Nations health and preventive care

First Nations health, determinants and cultural safety Community care, Item 715 and CTG medicines Immunisation and cancer screening entry points Screening pathways and primary CVD prevention

44 Epidemiological Metrics, Clinical Study Designs & Notifiable Communicable Diseases

Epidemiology, calculations, bias and surveillance

45 Neurological presentations

Stroke, TIA and focal weakness Headache, facial pain and vertigo Seizures, collapse and altered consciousness Numbness, movement disorders and generalised weakness

46 Musculoskeletal pain

Back, neck, bone and soft tissue pain

47 Eye presentations

Altered vision and retinal disease Red eye, ocular injury and discharge

48 Ear, nose, throat and oral health

Ear pain, hearing loss and tinnitus Nasal problems, neck lumps, hoarseness and dysphagia Toothache, mouth symptoms, dry mouth and halitosis

49 Skin, hair and nails

Rash, itch, infection and skin ulcers Skin lesions, hair loss and nail abnormalities

50 Breast health and feeding

Breast lumps, discharge and breastfeeding problems

51 Sexual and reproductive presentations

Genital symptoms, discharge and pelvic infection Menopause, prolapse and urinary symptoms Infertility and sexual dysfunction

52 Palliative care and carers

The dying patient, symptoms and carers

53 Eating disorders and personality care

Eating disorders, obesity and weight change Personality difficulties, self-harm and complex care

54 Sleep presentations

Insomnia, snoring and daytime sleepiness

55 Poisoning, resuscitation and environmental emergencies

Poisoning, toxidromes and antidote decisions Cardiopulmonary arrest, choking and emergency help Bites, stings, heat, cold and drowning

56 Communication, rights and professional practice

Communication, handover, errors and complaints Healthcare rights, inclusive care and equitable access Certificates, deaths, CPD and supervision Telehealth, images, prescribing and doctors' health

57 Genetics, research and donation

Genetic testing, research and organ donation

58 Travel, fever and outbreaks

Fever, travellers and outbreak response

Secondary hypertension and arterial disease

Key Takeaways Explain This Topic AI

Hypertensive emergency involves acute target-organ injury, not an elevated reading alone.

An ankle–brachial index below 0.9 supports peripheral arterial disease.

Rest pain, ulceration or gangrene requires urgent vascular assessment.

Last updated: October 2026

Secondary Hypertension: Diagnostic Evaluation and Management

Secondary hypertension accounts for approximately 5 % to 10 % 5\%\text{ to }10\% 5% to 10% of adult hypertension. It should be investigated when clinical "red flags" appear: age of onset < 30 years < 30\text{ years} < 30 years , abrupt or severe onset, resistant hypertension (blood pressure uncontrolled despite full doses of three concurrent antihypertensives including a diuretic), or unprovoked hypokalaemia.

Clinical comparison: Secondary Hypertension Etiologies, Clinical Clues, and Investigations

Renal Parenchymal Disease : Pathophysiological Mechanism: Glomerular/tubulointerstitial loss leading to salt/water retention; Clinical Presentation & Clues: Elevated creatinine, microscopic haematuria, proteinuria; First-Line Screening Test: Urinary albumin-to-creatinine ratio (uACR), eGFR, urinalysis; Confirmatory Diagnostic Test: Renal ultrasound (bilateral small, echogenic kidneys)

Renal Artery Stenosis : Pathophysiological Mechanism: Renal hypoperfusion stimulating the renin-angiotensin cascade; Clinical Presentation & Clues: Atherosclerotic in elderly smokers; Fibromuscular Dysplasia in young females; acute creatinine rise > 30 % > 30\% > 30% post-ACEi; First-Line Screening Test: Renal duplex Doppler ultrasound; Confirmatory Diagnostic Test: CT or Magnetic Resonance Angiography ("string-of-beads" in FMD)

Primary Aldosteronism : Pathophysiological Mechanism: Autonomous adrenal aldosterone secretion suppressing renin; Clinical Presentation & Clues: Resistant hypertension; unprovoked or diuretic hypokalaemia; muscle weakness; First-Line Screening Test: Morning paired Aldosterone-to-Renin Ratio (ARR) ; Confirmatory Diagnostic Test: Saline infusion test or fludrocortisone test; adrenal CT & adrenal venous sampling

Phaeochromocytoma : Pathophysiological Mechanism: Paroxysmal catecholamine hypersecretion by chromaffin tumour; Clinical Presentation & Clues: Classic triad: episodic headaches, profuse sweating, tachycardia; First-Line Screening Test: 24-hour urinary fractionated metanephrines or plasma free metanephrines; Confirmatory Diagnostic Test: Abdominal MRI / CT; MIBG or Ga-68 DOTATATE PET scan

Hypercortisolism: Exclude exogenous glucocorticoids first. Validated initial tests include overnight low-dose dexamethasone suppression, late-night salivary cortisol or urinary free cortisol. Confirmation and localisation are separate specialist steps; high-dose dexamethasone is not an initial screening test.

Obstructive sleep apnoea: Ask about snoring, witnessed pauses, daytime sleepiness and resistant hypertension. Diagnosis uses sleep testing and clinical context; an apnoea–hypopnoea index of at least 5 with relevant symptoms can meet criteria, so 15 is not the only diagnostic threshold.

Essential Pharmacological Rule for Phaeochromocytoma

In patients with suspected or confirmed phaeochromocytoma, alpha-adrenergic blockade (e.g., phenoxybenzamine) must always precede beta-adrenergic blockade . Initiating a beta-blocker alone blocks beta-2-mediated vasodilation while leaving alpha-1-mediated vasoconstriction completely unopposed, precipitating an extreme, potentially fatal hypertensive crisis. Beta-blockers are added only after several days of effective alpha-blockade to control reflex tachycardia.

Hypertensive Emergencies vs Urgencies

Hypertensive Emergency : Severe elevation in blood pressure (typically > 180 / 120 mmHg > 180/120\text{ mmHg} > 180/120 mmHg ) associated with acute, life-threatening target organ damage :

Neurological: Hypertensive encephalopathy, acute ischaemic stroke, intracranial haemorrhage.

Cardiovascular: Acute aortic dissection, acute coronary syndrome, acute pulmonary oedema.

Renal: Acute kidney injury with haematuria and proteinuria.

Ophthalmological: Advanced Grade IV hypertensive retinopathy (papilloedema, flame haemorrhages, cotton-wool spots).

Obstetric: Severe pre-eclampsia or eclampsia.

Management : Requires admission to an intensive care or high-dependency unit, continuous intra-arterial blood pressure monitoring, and titratable intravenous agents (e.g., sodium nitroprusside, labetalol, hydralazine, glyceryl trinitrate).

The 25% Rule : Blood pressure must be lowered gradually: decrease mean arterial pressure (MAP) by no more than 20% to 25% over the first hour , and then toward 160 / 100 mmHg 160/100\text{ mmHg} 160/100 mmHg over the subsequent 2 to 6 hours. Precipitous reduction impairs autoregulation and precipitates ischaemic stroke or myocardial infarction.

Critical Exceptions to the 25% Rule :

Acute Aortic Dissection : Requires rapid reduction of SBP to < 120 mmHg < 120\text{ mmHg} < 120 mmHg and heart rate to < 60 bpm < 60\text{ bpm} < 60 bpm within 20 minutes (using IV beta-blockers such as esmolol or labetalol first, followed by vasodilators).

Acute Ischaemic Stroke : Blood pressure is not lowered unless > 220 / 120 mmHg > 220/120\text{ mmHg} > 220/120 mmHg (permissive hypertension), or > 185 / 110 mmHg > 185/110\text{ mmHg} > 185/110 mmHg if the patient is eligible for intravenous thrombolysis.

Hypertensive Urgency : Severe elevation in blood pressure without acute target organ damage. Does not require intravenous therapy or emergency hospital admission. Managed in the outpatient setting with oral agents (e.g., intensifying maintenance therapy) with blood pressure brought down safely over 24 to 48 hours. Sublingual nifedipine is strictly contraindicated due to unpredictable precipitous hypotension and associated stroke and death.

Peripheral Arterial Disease (PAD)

Peripheral arterial disease results from systemic atherosclerosis causing progressive narrowing of lower extremity arteries:

Intermittent Claudication : Exertional muscle pain, aching, or fatigue (most commonly in the calf, but may involve the thigh or buttock) that is reproducible at a fixed walking distance and resolves completely within 2 to 5 minutes of standing still.

Chronic Limb-Threatening Ischaemia (CLTI) : Severe manifestation defined by ischaemic rest pain lasting > 2 weeks > 2\text{ weeks} > 2 weeks , non-healing ulcerations, or gangrene. Rest pain is classically worse at night when recumbent due to loss of gravitational hydrostatic pressure and improves when the patient hangs the leg over the edge of the bed.

Physical Examination : Absent or diminished pulses (femoral, popliteal, posterior tibial, dorsalis pedis), femoral bruits, cool pale extremities, trophic changes (hair loss, brittle nails, shiny thin skin), and Buerger test (marked elevation pallor followed by dependent rubor due to reactive hyperaemia). Arterial ulcers are deep, painful, "punched-out" lesions with necrotic bases, typically located over pressure points (tips of toes, lateral malleolus).

Ankle-Brachial Pressure Index (ABPI) Interpretation

ABPI is calculated by dividing the highest systolic pressure measured at each ankle (dorsalis pedis or posterior tibial) by the highest brachial systolic pressure using a Doppler ultrasound probe:

ABPI: At most 0.90 supports PAD; 0.91–0.99 is borderline, 1.00–1.40 is usually normal and above 1.40 suggests incompressibility. In diabetes/CKD, toe pressures and other vascular assessment may be needed. Rest pain, ulceration and gangrene require urgent assessment regardless of a reassuring number.

Comprehensive Management

Risk Factor Modification : Absolute, complete smoking cessation (the single most potent intervention to halt limb amputation); high-intensity statin therapy (atorvastatin 80 mg 80\text{ mg} 80 mg daily); blood pressure control ( < 130 / 80 mmHg < 130/80\text{ mmHg} < 130/80 mmHg ); and tight glycaemic control.

Antiplatelet Monotherapy : Aspirin 100 mg 100\text{ mg} 100 mg daily or clopidogrel 75 mg 75\text{ mg} 75 mg daily (clopidogrel showed slight superiority in the CAPRIE trial).

Supervised Exercise Therapy (SET) : The first-line conservative intervention for claudication. Involves structured treadmill walking to near-maximal pain for 30 to 45 minutes 30\text{ to }45\text{ minutes} 30 to 45 minutes , at least 3 times weekly for a minimum of 12 weeks, which stimulates collateral circulation.

Revascularization : Indicated for patients with CLTI (rest pain, tissue loss) or severe, lifestyle-limiting claudication refractory to medical therapy. Modalities include endovascular angioplasty/stenting or surgical bypass grafting (e.g., autologous saphenous vein femoropopliteal bypass).

Primary references (checked 7 October 2026): Australian CVD risk guideline .